109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
Recombinant DNA constructs and methods for controlling gene expression
#11702Recombinant DNA constructs and methods for controlling gene expression
#11703Recurrent gene fusions in prostate cancer
#11704MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer
#11705Positive controls for expression modulating experiments
#11706siRNA compounds and methods of use thereof
#11707Modulation of T cell signaling threshold and T cell sensitivity to antigens
#11708SiRNA targeting proto-oncogene MET
#11709Method For Searching Target Base Sequence Of Rna Interference, Method For Designing Base Sequence Of Polynucleotide For Causing Rna Interference, Method For Producing Double-Stranded Polynucleotide, Method For Inhibiting Gene Expression, Base Sequence Processing Apparatus, Program For Running Base Sequence Processing Method On Computer, Recording Medium, And Base Sequence Processing System
#11710Nucleic acid microspheres, production and delivery thereof
#11711Methods and Compositions Capable of Causing Post-Transcriptional Silencing of Gene Expression in a Synergic Manner
#11712Methods of treating eye diseases in diabetic patients
#11713NOVEL SIRNA COMPOUNDS FOR INHIBITING RTP801
#11714RNA interference mediating small RNA molecules
#11715Methods and Compositions for Treating Neurological Disease
#11716TAZ/WWTR1 for diagnosis and treatment of cancer
#11717MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE
#11718TRPM-2 antisense therapy
#11719Composition containing microRNA-21 inhibitor for enhancing radiation sensitivity
#11720NOVEL NUCLEIC ACID
#11721siRNA targeting amyloid beta (A4) precursor protein (APP)
#11722COMPOSITIONS FOR DELIVERY OF CARGO SUCH AS DRUGS PROTEINS AND/OR GENETIC MATERIALS
#11723RNA interference mediating small RNA molecules
#11724Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#11725Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#11726Modulation of GLUT4 Gene Promoter activity BY AHNAK
#11727High throughput methods for functionally determining RNA interference efficiency
#11728Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma
#11729RNA interference mediating small RNA molecules
#11730PTTG1 as a biomarker for cancer treatment
#11731RNAi probes targeting cancer-related proteins
#11732COMPOSITIONS AND METHODS OF TREATING NEOPLASIA
#11733Methods to increase or decrease bone density
#11734SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF
#11735METHODS OF INCORPORATING AMINO ACID ANALOGS INTO PROTEINS
#11736Inhibition of versican with siRNA and other molecules
#11737Further Use of Protein Kinase N Beta
#11738RNAi modulation of Aha and therapeutic uses thereof
#11739Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression
#11740Peptide-conjugated oligonucleotide therapeutic and method of making and using same
#11741siRNA targeting beta secretase (BACE)
#11742siRNA targeting apolipoprotein B (APOB)
#11743Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules
#11744METHOD OF INCREASING METABOLISM
#11745Decoy-containing pharmaceutical compositions and method of using the same
#11746Methods and compositions for the treatment of eye disorders with increased intraocular pressure
#11747Antidotes to antisense compounds
#11748EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS
#11749siRNA Targeting Survivin
#11750NLRR-1 antagonists and uses thereof
#11751Methods for expressing proteins in axons
#11752METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE
#11753Methods and sequences to suppress primate huntington gene expression in vivo
#11754RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
#11755Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
#11756METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#11757Lipid formulation
#11758Method for promoting angiogenesis, vascularization or vessel repair
#11759siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
#11760In vivo delivery of double stranded RNA to a target cell
#11761LM-1 ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME
#11762TH1-ASSOCIATED MICRORNAS AND THEIR USE FOR TUMOR IMMUNOTHERAPY
#11763Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof
#11764hnRNP K expression-inhibiting compound and siRNA sequence thereof
#11765Nucleic acid sequences comprising NF-κB binding site within O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter region and uses thereof for the treatment of cancer and immune-related disorders
#11766Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field
#11767MODULATION OF HIF1 BETA EXPRESSION
#11768Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair
#11769Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
#11770Methods and compositions for controlling efficacy of RNA silencing
#11771Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
#11772RNA interference mediating small RNA molecules
#11773CARRIER, METHOD AND REAGENT FOR OBTAINING SMALL RNA
#11774Families of non-cross-hybridizing polynucleotides for use as tags and tag complements, manufacture and use thereof
#11775Modulation of forkhead box O1A expression
#11776AGENT FOR REGULATING BONE FORMATION
#11777Method for down-regulating gene expression in fungi
#11778Modulation of stat5 expression
#11779LET-7 MICRORNA AND MIMETICS THEREOF AS THERAPEUTICS FOR CANCER
#11780Genes of an otitis media isolate of nontypeable
#11781Compositions and Methods for Controlling Hepatitis C Virus Infection
#11782POLYNUCLEOTIDE SEQUENCE FOR THE INHIBITION OF PHOSPHOLAMBAN SYNTHESIS
#11783MODULATING PRODUCTION TRAITS IN AVIANS
#11784MICRORNA MEDIATOR OF CARDIOMYOPATHY AND HEART FAILURE
#11785Compositions and methods for short interfering nucleic acid inhibition of Na1.8
#11786RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA
#11787NUCLEIC ACID CAPABLE OF REGULATING THE PROLIFERATION OF CELL
#11788Vectors and method for genetic immunization
#11789Reversible siRNA-based silencing of mutant and endogenous wild-type huntingtin gene and its application for the treatment of Huntington's disease
#11790MicromiRs
#11791COMPOSITIONS COMPRISING STAT3 SIRNA AND METHODS OF USE THEREOF
#11792Oligonucleotide Compositions with Enhanced Efficiency
#11793COMPOSITIONS AND METHODS FEATURING MICRONAS FOR TREATING NEOPLASIA
#11794Compositions and methods for inhibiting expression of Huntingtin gene
#11795POLYNUCLEOTIDE OR ANALOGUE THEREOF, AND GENE EXPRESSION REGULATION METHOD USING THE POLYNUCLEOTIDE OR THE ANALOGUE THEREOF
#11796METHODS FOR INHIBITING FASCIN
#11797Administering antisense oligonucleotides complementary to human apolipoprotein B
#11798RNA interference mediating small RNA molecules
#11799Micro-RNA scaffolds and non-naturally occurring micro-RNAs
#11800MicroRNA molecules
#11801Construct
#11802RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF
#11803Compounds and methods for improving cellular uptake of oligomeric compounds
#11804Compositions and methods for inhibiting or reversing fibrotic disorders
#11805Micrornas that regulate muscle cell proliferation and differentiation
#11806TARGETING OF RNA WITH EXTERNAL GUIDE SEQUENCES
#11807Methods and compositions for selecting siRNA of improved functionality
#11808REDUCER OF IMMUNOSUPPRESSION BY TUMOR CELL AND ANTITUMOR AGENT USING THE SAME
#11809Alternative export pathways for vector expressed RNA interference
#11810CANCER ASSOCIATED GENE LY6K
#11811Methods and compositions for modulating ErbB2 activity
#11812Anti-microRNA oligonucleotide molecules
#11813Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor
#11814Micro-RNAs modulating immunity and inflammation
#11815Identification of novel genes coding for small temporal RNAS
#11816Identification of novel genes coding for small temporal RNAs
#11817RNAi mediated knockdown of NuMA for cancer therapy
#11818siRNA-mediated gene silencing of synuclein
#11819MicroRNAs for inhibiting viral replication
#11820Pro-angiogenic genes in ovarian tumor endothelial cell isolates
#11821METHODS FOR INCREASING IN VIVO EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS
#11822Pharmaceutical composition comprising anti-mirna antisense oligonucleotide
#11823Method of inhibiting intimal hyperplasia
#11824Micro-RNA family that modulates fibrosis and uses thereof
#11825Hox Compositions and Methods
#11826TREATMENT OR PREVENTION OF INFLAMMATION BY TARGETING CYCLIN D1
#11827SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF
#11828Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
#11829Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method
#11830Treatment of hemoglobin (HBF/HBG) related diseases by inhibition of natural antisense transcript to HBF/HBG
#11831Combination treatment for the treatment of hepatitis C virus infection
#11832COMPOSITIONS COMPRISING HIF-1 ALPHA SIRNA AND METHODS OF USE THEREOF
#11833Therapeutic agent for wounds and screening method for the same
#11834COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS
#11835siRNA targeting interleukin-1 receptor-associated kinase 4(IRAK4)
#11836MicroRNA expression in human peripheral blood microvesicles and uses thereof
#11837Gene silencing of the brother of the regulator of imprinted sites (BORIS)
#11838Down-regulation of mortalin by siRNA
#11839METHODS OF GENERATING EXPANDED AND RE-DIFFERENTIATED ADULT ISLET BETA CELLS CAPABLE OF PRODUCING INSULIN
#11840METHODS AND COMPOSITIONS FOR MODULATING TISSUE FACTOR
#11841Modulation of apolipoprotein (A) expression
#11842COMPOSITIONS COMPRISING STAT5 SIRNA AND METHODS OF USE THEREOF
#11843COMPOSITIONS AND METHODS OF TREATING CANCER
#11844Human microRNAs and methods for inhibiting same
#11845INNATE IMMUNE SUPPRESSION ENABLES REPEATED DELIVERY OF LONG RNA MOLECULES
#11846Therapeutic uses of inhibitors of RTP801
#11847Micro-RNAs that control myosin expression and myofiber identity
#11848iRNA agents with biocleavable tethers
#11849Targeting microRNAs for the treatment of liver cancer
#11850Method for inhibiting the activity of mir-155
#11851RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
#11852METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE
#11853Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
#11854LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
#11855DIFFERENTIAL EXPRESSION OF MICRORNAS IN NONFAILING VERSUS FAILING HUMAN HEARTS
#11856siRNA targeting cyclin dependent kinase 11 (CDK11)
#11857siRNA targeting KRAS
#11858Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#11859Formation/elongation of axon by inhibiting the expression or function of Singar and application to nerve regeneration
#11860Dinucleotide MRNA cap analogs
#11861USE OF SHORT OLIGONUCLEOTIDES FOR REAGENT REDUNDANCY EXPERIMENTS IN RNA FUNCTIONAL ANALYSIS
#11862Method of diagnosing poor survival prognosis colon cancer using microRNA-21
#11863Transgenic animals comprising gene fusions
#11864Oligonucleotides for modulating target RNA activity
#11865Micro-RNA scaffolds, non-naturally occurring micro-RNAs, and methods for optimizing non-naturally occurring micro-RNAs
#11866METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#11867Dendritic cell vaccine compositions and uses of same
#11868METHOD FOR PROLONGING LONGEVITY
#11869SHORT RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF HIF-1ALPHA
#11870Modulators of pharmacological agents
#11871Method for the production of a cell and/or tissue and/or disease phase specific medicament
#11872Oligomeric compounds and compositions for use in modulation of pri-miRNAs
#11873MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES
#11874siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
#11875Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same
#11876Therapeutic compositions
#11877Antisense modulation of kinesin-like 1 expression
#11878METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#11879LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS
#11880Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
#11881SiRNA targeting glucagon receptor (GCGR)
#11882Development of universal cancer drugs and vaccines
#11883MicroRNA Antisense PNAs, Compositions Comprising the Same, and Methods for Using and Evaluating the Same
#11884Detection of CXADR protein for diagnosis of kidney cancer
#11885Enigma-Mdm2 interaction and uses thereof
#11886BACTERIAL MEDIATED TNF ALPHA GENE SILENCING
#11887siRNA target hypoxia-inducible factor 1
#11888siRNA targeting gremlin
#11889Vivo production of small interfering RNAs that mediate gene silencing
#11890Antibacterial antisense oligonucleotide and method
#11891ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND
#11892DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
#11893In vivo production of small interfering RNAS that mediate gene silencing
#11894Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof
#11895Compositions and methods for the delivery of biologically active RNAs
#11896RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#11897RNA antagonist compounds for the inhibition of Apo-B100 expression
#11898RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)
#11899Compositions comprising MIR34 therapeutic agents for treating cancer
#11900Dnazymes and sensors incorporating the same
#11901Recombinant DNA constructs and methods for controlling gene expression
#11902siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof
#11903Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof
#11904Compositions and methods for reducing or protecting against delayed graft function (DGF)
#11905Methods and compositions for treatment of cystic fibrosis
#11906High potency siRNAS for reducing the expression of target genes
#11907Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases
#11908SUPPRESSION OF TLA1 GENE EXPRESSION FOR IMPROVED PHOTOSYNTHETIC PRODUCTIVITY
#11909Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression
#11910Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
#11911Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
#11912Drug delivery product and methods
#11913Nucleic acids for inhibiting hairless protein expression and methods of use thereof
#11914Methods to regulate miRNA processing by targeting Lin-28
#11915METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#11916METHODS OF IDENTIFYING AND USING SNAIL1 INHIBITORY COMPOUNDS IN CHONDRODYSPLASIA TREATMENT AND PREPARATION OF PHARMACEUTICAL COMPOSITIONS
#11917IMMUNE SYSTEM MEDIATOR
#11918Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
#11919AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL
#11920RNAi modulation of APOB and uses thereof
#11921Compositions and methods for modulation of SMN2 splicing
#11922KRUPPEL-LIKE FACTORS AND FAT REGULATION
#11923VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS
#11924Short oligomer antagonist compounds for the modulation of target mRNA
#11925Small activating RNA molecules and methods of use
#11926Nicked or gapped nucleic acid molecules and uses thereof
#11927Targeting PAX2 for the treatment of breast cancer
#11928Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#11929APCDD1 inhibitors for treating, diagnosing or detecting cancer
#11930Method and carrier complexes for delivering molecules to cells
#11931OLIGONUCLEOTIDE COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#11932Compositions and methods for inhibiting expression of the HAMP gene
#11933Method of Treating Neurodegenerative Disease
#11934Isolated stem cell comprising a Xic flanking region transgene
#11935DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER ASSOCIATED CHROMOSOMAL FEATURES
#11936GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION AND USES THEREOF
#11937Treating Hepatitis C Virus Infection
#11938Modulation of Stat 6 Expression for the Treatment of Airway Hyperresponsiveness
#11939Tissue-specific MicroRNAs and compositions and uses thereof
#11940Antisense compounds
#11941Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
#11942Compositions and methods for modulating ghrelin-mediated conditions
#11943Modulation of blood brain barrier protein expression
#11944METHOD AND SYSTEM FOR BIASING CELLULAR DEVELOPMENT
#11945SiRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)
#11946DELIVERY OF NUCLEIC ACIDS USING CELL-PENETRATING PEPTIDES
#11947COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY
#11948RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES
#11949siRNA-MEDIATED GENE SILENCING WITH VIRAL VECTORS
#11950P53 modulator and cancer target
#11951Isolation of novel AAV'S and uses thereof
#11952Methods and compositions for post-transcriptional gene silencing
#11953EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION
#11954METHODS AND MEANS FOR TREATING DNA REPEAT INSTABILITY ASSOCIATED GENETIC DISORDERS
#11955RNAi modulation of SCAP and therapeutic uses thereof
#11956Methods and compositions for enhancing the efficacy and specificity of RNA silencing
#11957Methods and compositions for enhancing the efficacy and specificity of RNA silencing
#11958Methods and compositions for enhancing the efficacy and specificity of RNA silencing
#11959RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
#11960Compositions and methods for modulating angiogenesis
#11961COMPOSITIONS AND METHODS FOR INHIBITING GENE SILENCING BY RNA INTERFERENCE
#11962Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules
#11963Nucleic acids involved in viral infection
#11964Method for determining MIF content
#11965SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX
#11966Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof
#11967Therapies for cancer using RLIP76
#11968Chimeric DRG11-responsive (DRAGON) polypetides
#11969Compositions and Methods of Using RNA Interference for Control of Nematodes
#11970Methods and Compositions Involving miRNAs In Cancer Stem Cells
#11971GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF CANCERS
#11972AMPHIPHILIC NUCLEOTIDE COCHLEATE COMPOSITIONS AND METHODS OF USING THE SAME
#11973Extended dicer substrate agents and methods for the specific inhibition of gene expression
#11974Eukaryotic layered vector initiation systems
#11975Double-stranded nucleic acid molecule cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer, and bladder cancer
#11976Enhanced biotherapeutic production using inhibitory RNA
#11977Compositions and methods for cancer diagnosis and therapy
#11978METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#11979Methods and compositions for cellular reprogramming
#11980Rna constructs
#11981FGFR4 antibodies
#11982Oligomers
#11983RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)
#11984GNAQ targeted dsRNA compositions and methods for inhibiting expression
#11985Therapeutic uses of inhibitors of RTP801L
#11986Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics
#11987Novel Oligonucleotide and NF-kB Decoy Comprising the Same
#11988Genes of an otitis media isolate of nontypeable
#11989Antagonists of bacterial sequences
#11990siRNA compositions and methods for potently inhibiting viral infection
#11991Nucleic acid silencing sequences
#11992Treating picornavirus infection by targeting MicroRNA miR-141
#11993METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TURMORGENICITY
#11994Method for treatment of Huntington's disease through intracranial delivery of sirna
#11995MODULATION OF SID-1 EXPRESSION
#11996RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
#11997siRNA targeting BCL2L1
#11998OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA
#11999siRNA targeting nucleoporin 62kDa (Nup62)
#12000Methods for Differentiating Pancreatic Cancer from Normal Pancreatic Function and/or Chronic Pancreatitis